共 50 条
- [21] COMBINATION CHEMOTHERAPY WITH DAUNORUBICIN, CYTOSINE-ARABINOSIDE AND PREDNISOLONE (DAP) IN ACUTE NONLYMPHOCYTIC LEUKEMIA ACTA HAEMATOLOGICA JAPONICA, 1981, 44 (04): : 881 - 886
- [22] INTERMEDIATE-DOSE OF CYTOSINE-ARABINOSIDE FOR CONSOLIDATION CHEMOTHERAPY IN ELDERLY PATIENTS WITH ACUTE NONLYMPHOCYTIC LEUKEMIA CANCER RESEARCH THERAPY & CONTROL, 1993, 3 (04): : 289 - 295
- [23] MECHANISMS OF RESISTANCE TO 6 DAY HIGH-DOSE CYTOSINE-ARABINOSIDE (ARAC) THERAPY IN PATIENTS WITH ACUTE NONLYMPHOCYTIC LEUKEMIA (ANLL) PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1983, 24 (MAR): : 165 - 165
- [24] HIGH-DOSE CYTOSINE-ARABINOSIDE THERAPY IN ACUTE NON-LYMPHOCYTIC LEUKEMIA EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1984, 20 (02): : 297 - 300
- [28] CYTOSINE-ARABINOSIDE (NSC-63878) AND DAUNORUBICIN (NSC-83142) THERAPY IN ACUTE NONLYMPHOCYTIC LEUKEMIA CANCER CHEMOTHERAPY REPORTS PART 1, 1973, 57 (04): : 485 - 488